Domov › Ťažká depresívna porucha › Florida › Tampa
Klinické štúdie Ťažká depresívna porucha v meste Tampa, FL
17 štúdií pre Ťažká depresívna porucha hľadá účastníkov v zariadeniach v meste Tampa a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Prebieha náborFáza 2
- IPTB Clinical Research, Tampa
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Prebieha náborFáza 3
- K2 Medical Research Tampa, Tampa
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Prebieha náborFáza 3
- K2 Medical Research (Tampa), Tampa
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Prebieha náborFáza 3
- K2 Medical Research - Tampa, Tampa
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Prebieha náborFáza 3
- IPTB Clinical Research, Tampa
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Prebieha náborFáza 3
- Interventional Psychiatry of Tampa Bay, Tampa
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Prebieha náborFáza 3
- Psych Me Medical Research Inc, Tampa
- Interventional Psychiatry of Tampa Bay, Tampa
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Prebieha náborFáza 2
- K2 Medical Research - Tampa, Tampa
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Prebieha náborFáza 4
- Neurocrine Clinical Site, Tampa
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Prebieha náborFáza 2
- Draig Clinical Site, Tampa
- Draig Clinical Site, Tampa
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Prebieha nábor
- USF Health, Tampa
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Prebieha náborFáza 3
- Neurocrine Clinical Site, Tampa
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Prebieha náborFáza 3
- Neurocrine Clinical Site, Tampa
- Neurocrine Clinical Site, Tampa
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Prebieha náborFáza 3
- Neurocrine Clinical Site, Tampa
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Prebieha náborFáza 2
- University of South Florida, Psychiatry and Behavioral Neurosciences, Tampa
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
Prebieha náborFáza 2
- Autobahn Site #148, Tampa
Study of ALTO-300 in MDD
Prebieha náborFáza 2
- Site 221, Tampa
Štúdie Ťažká depresívna porucha v iných mestách
- New York City, NY36 štúdií
- Boston, MA31 štúdií
- Atlanta, GA25 štúdií
- Philadelphia, PA23 štúdií
- Orlando, FL19 štúdií
- Miami, FL18 štúdií
- Chicago, IL17 štúdií
- San Diego, CA16 štúdií
- Houston, TX16 štúdií
- Little Rock, AR14 štúdií
- Austin, TX13 štúdií
- Las Vegas, NV13 štúdií
Iné štúdie v Tampa
- Nemalobunkový karcinóm pľúc51 štúdií
- Rakovina prsníka43 štúdií
- Rakovina (všetky typy)39 štúdií
- Kolorektálny karcinóm34 štúdií
- Akútna myeloidná leukémia29 štúdií
- Metastatická rakovina29 štúdií
- Rakovina pľúc29 štúdií
- Rakovina pankreasu26 štúdií
- Rakovina vaječníkov21 štúdií
- Melanóm19 štúdií
- Myelodysplastické syndrómy19 štúdií
- Rakovina prostaty18 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.